CBD may be a useful treatment for various breast cancer subtypes, according to a new study published by the journal The Breast. “Studies have emphasized an antineoplastic effect of the non-psychoactive, phyto-cannabinoid, Cannabidiol (CBD)”, begins the study’s abstract, which was epublished ahead of print by the National Institute of Health. “However, the molecular mechanism underlying …
A new study being published in the upcoming issue of the journal Expert Opinion on Investigational Drugs, and published online ahead of print by the U.S. National Institute of Health, has found that cannabinoids may be a promising tool for the treatment of breast and prostate cancer. According to the study’s abstract; “The aim of …
Cannabidiolic acid (CBDA), a little-known compound found in cannabis, can inhibit the migration of highly aggressive breast cancer, according to a study published by the Journal of Natural Medicines and published online by the National Institute of Health. “The biological activities of CBDA have been attracting increasing attention”, states the study’s researchers, who “identified CBDA …
A new study published in the journal Molecular Oncology, and published online by the National Institute of Health, has found that the cannabis compound cannabidiol inhibits the growth and metastasis of highly aggressive breast cancer. “The anti-tumor role and mechanisms of Cannabidiol (CBD), a non-psychotropic cannabinoid compound, are not well studied especially in triple-negative breast …
A nearly 10-year long study conducted by researchers at California Pacific Medical Center’s Research Institute, and published this month by the British Journal of Pharmacology, has found that cannabinoids can combat breast cancer progression. “The psychoactive cannabinoid Δ9 -tetrahydrocannabinol (THC) and the non-psychoactive cannabinoid cannabidiol (CBD) can both reduce cancer progression each through distinct antitumor …
A new study published by the British Journal of Pharmacology has found that not only can CBD (cannabidiol, a cannabis compound) protect breast cancer patients against neurotoxicity and pain associated with chemotherapy drugs, it can actually increase the cancer-fighting capabilities of these drugs. According to researchers; “Paclitaxel (PAC) is associated with a chemotherapy-induced neuropathic pain (CIPN) …
